Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,214.00    114.00 (0.81%)
Bid:
14,214.00
Ask:
14,218.00
Spread: 4.00 (0.028%)
Market Cap: £220.44b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

TOP NEWS: AstraZeneca appoints replacement for detained China boss
4 Dec 2024

TOP NEWS: AstraZeneca appoints replacement for detained China boss

(Alliance News) - AstraZeneca PLC on Wednesday appointed Iskra Reic as its new international executive vice president, replacing Leon Wang, who has be...

LONDON MARKET CLOSE: Blue-chips in the red despite European, US gains
4 Dec 2024

LONDON MARKET CLOSE: Blue-chips in the red despite European, US gains

(Alliance News) - Stocks in London ended mixed on Wednesday, with the FTSE 100 held back by falls in AstraZeneca plus uninspiring data, while mid-caps...

AstraZeneca appoints Iskra Reic as vice-president of intl unit
4 Dec 2024

AstraZeneca appoints Iskra Reic as vice-president of intl unit

(Sharecast News) - AstraZeneca said it had appointed AstraZeneca today announced the appointment of Iskra Reic as Executive Vice President (EVP), Inte...

LONDON MARKET MIDDAY: FTSE 100 underperforms before US jobs data
4 Dec 2024

LONDON MARKET MIDDAY: FTSE 100 underperforms before US jobs data

(Alliance News) - London's FTSE 100 faltered, but European peers climbed and US stocks are called to open higher, with focus turning to US jobs data a...

TOP NEWS: AstraZeneca hails positive Truqap data on prostate cancer
25 Nov 2024

TOP NEWS: AstraZeneca hails positive Truqap data on prostate cancer

(Alliance News) - AstraZeneca PLC on Monday said its Truqap combination in a type of prostate cancer showed a statistically significant improvement in...

AstraZeneca reports positive results from prostate cancer trial
25 Nov 2024

AstraZeneca reports positive results from prostate cancer trial

(Sharecast News) - AstraZeneca announced positive results from a phase three prostate cancer trial on Monday, reporting that its AKT inhibitor 'Truqap...

LONDON BROKER RATINGS: United Utilities raised; HSBC cuts easyJet
20 Nov 2024

LONDON BROKER RATINGS: United Utilities raised; HSBC cuts easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

LONDON BRIEFING: Sage announces buyback; Ninety One in Sanlam deal
20 Nov 2024

LONDON BRIEFING: Sage announces buyback; Ninety One in Sanlam deal

(Alliance News) - The FTSE 100 is called to open flat on Wednesday, after a hotter than expected UK inflation reading.